Stigmasterol.
Research-backed compound with potential health benefits. Blocks cholesterol absorption in your gut. It basically gets in the way of dietary and biliary cholesterol, so less of it enters your bloodstream.
Reviewed March 2026
- Category
- Compound
What Stigmasterol is, and what it does.
- Does it work
- Maybe. If your LDL cholesterol is borderline high and you want to try something before statins, it's a reasonable option. Not a must-have for everyone.
- How much to take
- Studies use 1.5-3 grams of total plant sterols daily. Stigmasterol is part of that blend. Aim for that range, split between two meals.
- Time to feel it
- No sensation marks the start. Controlled trials read the change off a lipid panel after four to twelve weeks of taking it with meals.
- The first dose
- Nothing. This isn't a stimulant. It works slowly in your digestive system.
- With regular use
- After 2-3 months of consistent use with meals, you could see a 5-10% reduction in your LDL cholesterol. That's the main goal.
- How well tolerated
- Well tolerated in most. Can slightly lower fat-soluble vitamin absorption. If you have a rare condition called sitosterolemia, this is a hard no.
- How it feels
- Like nothing. It's an invisible worker. All the action shows up on your lipid panel, not in your daily feeling.
- The overlooked benefit
- Stigmasterol is the classical starting material for making steroid intermediates in a factory, because its side chain can be cleaved to leave a usable steroid nucleus.
400 to 1,000mg a day is where Stigmasterol works.
Source: Plant sterol; part of the sterol/stanol evidence base. Abumweis et al., Eur J Clin Nutr, 2008
The proof, claim by claim.
These words describe the research, not the molecule's worth. Research strength is how much work stands behind one claim, and it is never a product score.
Stigmasterol is documented in the library; the clinical read is in the queue. Nothing about the strength of the research prints until the read is done.
- Cholesterol absorption in the gutRandomised trial
- LDL cholesterol already in the normal rangeMeta-analysis
- Carotenoid levels alongside sterol intakeMeta-analysis
- Healthy inflammatory responseAnimal study
Questions people ask about Stigmasterol.
- Is this a replacement for statins?
- No. It's a milder tool. Your doctor might suggest it for borderline numbers, but it doesn't replace prescription meds for high-risk patients.
- Do I have to take it with food?
- Yes. Take it with your meals, especially ones containing fat. It needs to be in your gut at the same time as cholesterol to work.
- Will it lower my total cholesterol?
- It mostly targets LDL, the 'bad' cholesterol. You'll see the biggest and most important drop there.
- Is it the same as beta-sitosterol?
- They're cousins. Both are plant sterols and work the same way. Most supplements contain a mix of several types, including both.
- Can I get enough from my diet?
- It's tough. You'd need to eat a massive amount of nuts, seeds, and specific vegetable oils daily to hit the 2-gram therapeutic dose.
- Any side effects?
- Rare. Some people report mild digestive upset. The main biochemical effect is slightly reduced absorption of vitamins A, D, E, and K.
Why these belong in the same formula. Each row says what the basis is, from settled biochemistry through to a trial that measured the pair.
Stigmasterol and sitosterol are the two dominant plant sterols and both displace cholesterol from intestinal micelles at the NPC1L1 uptake step. They arrive together and their doses add.
Brassicasterol competes for the same micellar space and the same uptake transporter. Total plant sterol load determines the effect, not any single member.
Plant sterols crowd out carotenoids from the mixed micelle that ferries both across the gut wall, so carotenoid levels fall with steady sterol intake.
Lutein needs bile salt micelles for absorption and plant sterols occupy that space. Taken in the same meal, sterol intake lowers lutein uptake.
Tocopherol shares the micellar absorption route that plant sterols compete in, so serum tocopherol tends to track downward with regular sterol use. Separating the doses limits the overlap.
Menaquinone is fat-soluble and absorbed through the same bile-dependent micellar step. Large sterol doses at the same meal reduce how much is taken up.
Viscous psyllium fibre removes bile acids while the sterol blocks cholesterol re-entry at the micelle. Two different points in the enterohepatic loop, so the effects add.
Berberine raises hepatic LDL receptor expression through a post-transcriptional route while the sterol limits intestinal cholesterol uptake. The two act on clearance and on absorption respectively.
Plant sterols only compete with cholesterol once they are inside a bile salt micelle, so bile salt availability sets how much of the sterol dose does anything. Where bile output is low the sterol passes through undissolved.
Stigmasterol is a lipophilic sterol with very low water solubility, so it has to enter mixed micelles before it can act at the brush border. A lipid vehicle such as medium chain triglyceride gives the sterol somewhere to dissolve and prompts bile release. This is why sterol preparations are commonly dosed with a fat-containing meal or a lipid carrier.
Free stigmasterol crystallises readily and disperses poorly in water-based formats. Phospholipid emulsifiers keep the sterol in a fine dispersion so it does not settle out of a beverage or softgel fill. The pairing is formulation convention rather than a physiological effect.
Biliary phosphatidylcholine is one of the components that builds the mixed micelle in which sterols are carried through the unstirred water layer. Supplying phospholipid alongside a sterol supports that dispersion step. The relationship is physical chemistry, not a claimed clinical outcome.
Vitamin D3 is itself a secosteroid absorbed through the same micellar route stigmasterol occupies. Plant sterols reduce the micellar space available to other lipophilic molecules, so co-ingestion at the same meal is a plausible competition. The direction is mechanistic; separating the two doses by a few hours is the usual formulation answer.
Retinyl esters travel in the same mixed micelles that carry plant sterols. Sterol loads high enough to displace cholesterol from those micelles can also displace other lipophilic passengers. This is a mechanistic expectation, not a measured deficit in people taking ordinary intakes.
Carotenoids and plant sterols compete for the same micellar carrier in the gut lumen. Plasma carotenoid concentrations are a marker of circulating supply, not an outcome, and the usual formulation response is to include carotenoid-rich food or a separate carotenoid source. Regard the interaction as an absorption effect rather than a functional loss.
Ubiquinone is highly lipophilic and depends on the same micellar handling as sterols. Direct measurement of this specific pairing is thin, so the expectation rests on shared chemistry rather than a trial. Dosing them at different meals is the low-cost way to sidestep the question.
Astaxanthin is a xanthophyll carried in mixed micelles and then in lipoproteins, the same path a phytosterol occupies. The competition is inferred from the shared route rather than measured for this pair. Both are commonly formulated with a lipid carrier, which partly offsets the crowding.
Phylloquinone is a fat-soluble vitamin absorbed with dietary lipid. A high sterol load at the same meal competes for the same micellar capacity. The interaction is mechanistic and has not been measured for stigmasterol specifically.
Viscous oat beta-glucan increases the faecal loss of bile acids, while a plant sterol reduces how much cholesterol is picked up from the micelle. The two act at different points, so the combination is complementary rather than redundant. This supports the body's normal handling of dietary and biliary cholesterol.
Pectin forms a viscous gel that slows micelle diffusion and carries bile acids into the stool. Stigmasterol works on the composition of that micelle instead. The pairing is common in fibre plus sterol blends and rests on established luminal physiology.
Glucomannan raises the viscosity of intestinal contents, which slows the movement of mixed micelles toward the brush border. A sterol changes what those micelles carry. Adequate fluid is part of dosing any high-viscosity fibre alongside a sterol.
Guar gum thickens luminal contents and increases bile acid excretion, a different lever from the micellar displacement a sterol produces. Partially hydrolysed grades give less viscosity and less of this effect. The pairing is a formulation staple in fibre blends.
Stigmasterol supplied as a fatty acid ester is not active until pancreatic carboxyl ester lipase releases the free sterol in the lumen. Pancreatic enzyme preparations supply that hydrolytic activity. Free-sterol preparations do not depend on this step.
Long chain triglycerides provide the fat phase a sterol needs for micellar dispersion, and marine oils are frequently the carrier in softgel sterol products. The two also act on different parts of lipid handling, absorption versus hepatic triglyceride assembly. Read the pairing as complementary rather than a single shared mechanism.
Tocotrienols and phytosterols are both recovered from vegetable oil deodoriser distillate and often appear in the same lipid-support formulas. They act on different steps, one in the antioxidant network and one at absorption. The combination has not been measured as a pair.
Red yeast rice contains monacolin K, which acts on endogenous sterol synthesis, while stigmasterol acts on how much dietary and biliary cholesterol is picked up in the gut. The two levers are separate, which is why the pairing appears in lipid-support blends. Monacolin-containing products carry their own interaction considerations and warrant clinician input.
Nothing specific on file for Stigmasterol. Match the label to the daily amount above, and tell your doctor what you take.
Not medical advice. Show the label to your pharmacist.What Stigmasterol actually does.
Stigmasterol is a 4-desmethyl plant sterol whose ring structure closely resembles cholesterol, differing at the side chain by an ethyl group and an additional double bond.
Because it is structurally close to cholesterol, stigmasterol competes with cholesterol for a limited number of places in intestinal mixed micelles, which reduces how much cholesterol reaches the enterocyte brush border.
Plant sterols that do enter the enterocyte are largely pumped back into the lumen by the ABCG5 and ABCG8 transporters, which is why systemic absorption of stigmasterol is a small fraction of that of cholesterol.
Uptake at the brush border runs through the NPC1L1 sterol transporter, which handles cholesterol and plant sterols alike and is the point at which the two compete.
Where Stigmasterol comes from.
It comes from the leftovers of vegetable oil refining, usually soy or corn, or from pine wood processing. The plant sterols in that stream are concentrated, then crystallised over and over to separate stigmasterol from its very similar cousins. What ends up in a capsule is either the plain sterol powder or an oil-soluble ester of it.
Made from a plant. What ends up in the capsule tracks the harvest, so batch testing and a stated marker matter more here than with a made molecule.
The starting material is a side stream of edible oil refining, most often soybean or corn oil, or crude tall oil soap from wood pulping. Both carry a natural sterol fraction in which stigmasterol occurs alongside other sterols.
The distillate is saponified and the unsaponifiable matter separated by solvent extraction or molecular distillation, which concentrates total sterols away from free fatty acids and glycerides.
The sterol concentrate is repeatedly crystallised from solvent to separate stigmasterol from the structurally similar beta-sitosterol and campesterol, which is the demanding step because the sterols differ only in the side chain.
The sterol profile is quantified by GC or GC-MS against reference standards, and the certificate reports the stigmasterol share along with residual sterols and solvent.
The purified sterol is milled as a free sterol powder, or esterified with a food fatty acid to give an oil-miscible ester for lipid formats.
Getting Stigmasterol from food.
The whole-food sources on file. A supplement closes the gap, it does not replace dinner.
A gram-for-gram figure (how much of each you would eat to match a dose) will appear here once it is sourced and reviewed. This page will not print a number it cannot cite.
The forms it comes in.
The essence, in one line each.
- Across 28 randomised trials in 1,777 adults, phytosterol supplementation as a class lowered total cholesterol, LDL cholesterol and apolipoprotein B and raised HDL cholesterol, with a dose-response pattern; the trials tested phytosterol mixtures, not stigmasterol on its own.Meta-analysis. Zhang et al., 2024 (Medicine). PMID 39432657 ↗
- In 14 randomised trials covering 1,088 adults with raised blood lipids, phytosterol-rich foods lowered LDL cholesterol by a mean difference of 0.52 (95% CI 0.38 to 0.66) and total cholesterol by 0.65, while C-reactive protein showed no detected change.Systematic review. Zhang et al., 2025 (Frontiers in Pharmacology). PMID 40672367 ↗
- In a 9-week placebo-controlled pilot in adults on a gluten-free diet with raised cholesterol, a plant sterol and stanol supplement combined with a probiotic lowered total cholesterol, LDL cholesterol and apolipoprotein B at several timepoints, in a small exploratory sample that cannot separate the sterols from the probiotic.Randomised trial. Costabile et al., 2026 (Molecules). PMID 42197276 ↗
- The authors report that stigmasterol supplementation altered cardiac tissue morphology and oxidative stress markers in a doxorubicin toxicity model; these are tissue markers, not clinical outcomes.Animal study. Wang Y. et al., 2026 (Folia morphologica). PMID 40145712 ↗
- In mice, stigmasterol shifted bile acid composition and gut microbial profile, which the authors identify as the route behind the observed change in biliary cholesterol handling.Animal study. Deng D et al., 2026 (The Journal of Nutritional Biochemistry). PMID 41106611 ↗
- The authors report that stigmasterol reduced inflammatory signalling and lipid loading in macrophage-derived foam cells in a preclinical vascular model.Preclinical study (cultured cells). Lu B et al., 2025 (iMetaOmics). PMID 41676448 ↗
- Stigmasterol appears as a named constituent in the network pharmacology component of this review of traditional Chinese herbal formulas in adults with elevated blood glucose measures; it was not tested on its own, and the constituent analysis is computational.Meta-analysis. Tang S et al., 2025 (Frontiers in Endocrinology). PMID 41127514 ↗
- Stigmasterol is named among the constituents identified by multi-omics analysis of a Pulsatilla chinensis preparation; the row is mechanistic and the compound was not given alone.Animal study. Zhao Z et al., 2026 (Biomolecules). PMID 42194001 ↗
These are the studies our verdict leans on, chosen from the 1,330 we read for Stigmasterol. The full linked list is below.
FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. This information is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting any supplement regimen.